GcMAF Nagalase, Autism And Cancer Cure— What Is The Story

Dave Clark

Member
Joined
Jun 2, 2017
Messages
1,978
I don't know much except that apparently a bunch of doctors around the world, I believe US and Europe, were using injectable GcMAF in their clinics to cure cancer. Next thing you know these doctors started showing up dead in mysterious ways, some from gun shot wounds, etc. If you do a search on it you will find info on people's conspiracy theory about this strange death of doctors using this modality. I can't remember much more about it right now.
 
Joined
Nov 27, 2017
Messages
960
Paul Cheney Seminar (2013)


The treatment for nagalase elevation is GcMAF.

When we saw elements of nagalase activity – by the way, that was one of the things that so confused us. We were looking around with a hostile retrovirus infection. We know that retrovirus envelope produces nagalase activity. All these patients have nagalase activity. But we can’t find the retrovirus.

But HERVs – human endogenous retroviruses – when expressed make envelope protein.

It could be that the nagalase activity is coming from the human endogenous retrovirus activity.

So we decided to try GcMAF therapy, based on this observation of nagalase.



Screenshot-386.png


GcMAF Therapy

Natalase is an enzyme activity in the blood that destroys the precursor for GcMAF.

GcMAF is very important for immunocompetence.

So you can imagine which diseases have nagalase activity.

The disease with the highest nagalase activity is a retroviral disease called AIDS.

AIDS patients have the highest nagalase activity because they have because they have highly expressed HIV envelope protein, which carries the nagalase activity.

The next highest nagalase activity is in cancer patients. Most cancer patients, if not all cancer patients, have nagalase activity.

Nagalase activity may, in fact, produce immunoincompetence, which is why cancer patients don’t survive.

What survival requires is not only getting the core cancer but also bringing back immune competence.

If nagalase is elevated, they will never have immune competence, and it will probably be incurable if you don’t get the primary cancer.

So our patients’ nagalase activity averages that of a cancer patient, approximately 3.5.

We also found that if you plotted the clinical severity, where 100 is normal and 30 is intensive care unit, you’ll notice that there’s kind of a regression line. The higher the nagalase gets, the sicker the patients are.

By the way, similar to HIV. You see this same kind of regression curve in HIV.

We’re really very excited about this, because by using GcMAF – which is known to to knock out nagalase – we might be able to restore immune competence to our patients.



Screenshot-387.png




Screenshot-388.png


GcMAF is part of the Vitamin D access.

At dinner I had a discussion with a physician who’s interested in Vitamin D metabolism.

It turns out that Gc protein and GcMAF and Vitamin D are all integrated in a very complicated and very regulated access called Vitamin D access.

Activated T-cells and B-cells tend to deglycosylate the Vitamin D binding protein producing GcMAF, which is necessary for immunocompetence.



Screenshot-389.png




Screenshot-390.png




Screenshot-391.png


We found that there were indicators of who would response based on calcitriol response.

Calcitriol is a very powerful hormone. Vitamin D is converted into calcitriol by different cell types.

We found that if the calcitriol was either high or low, and moved to the mid range, those were responders.

But if the calcitriol stayed low or stayed high, they were non-responders.

Vitamin D made no difference. Only the active form of Vitamin D seemed to predict response.

It wasn’t the pre-treatment with the calcitrol. It was the predicted response.



Screenshot-395-1231x1024.png


GcMAF Assessment

This is the clinical assessment we used.



Screenshot-394.png




Screenshot-396.png


We also so a degradation of nagalase activity, which was nice to see.

Not impressively so, in the case of chemical GcMAF, but it did drop.



Screenshot-397.png


This is the calcitrol.

The best responders are in white. You’ll notice that they tended to rise from low values to medium values.

Non-responders tended to remain the same, to not respond.

Non-responders tended to be somewhat high sometimes, but to move toward the middle.

I don’t understand the reason for this, but this seemed to be a characteristic of response and non-response – how the Vitamin D axis responded to GcMAF.



Screenshot-399.png


This is just a summary of those findings I mentioned earlier.



Screenshot-400-1407x1024.png


Probiotic GcMAF

Then we decided to turn to another type of GcMAF, using probiotic GcMAF.

This is not made in a laboratory from human gammaglobulin, but made with yogurt and kefir.

This was developed by Marco Ruggiero and his wife at the University of Florence.

They came all the way over because they had developed this probiotic form of GcMAF.

This is the Gc protein, which is a Vitamin D protein, which has three sugar molecules.

And you can progressively lop off one sugar molecule, and then lop off the second sugar molecule, leaving a final one.

You’ve converted Gc protein to GcMAF.

The enzymes that do this are interestingly present in in probiotics, which was discovered by Ruggiero.

So he figured out which type of probiotic would produce this kind of deglycosolation.

He found a yogurt that he designed that would lop off one sugar, and a kefir that he designed that would lop off the other sugar.

So we will have the patients make a yogurt with one group of ferment that he developed, and then make a kefir with another group of ferment that he developed, and then mix them together, and you get GcMAF in the probiotic.

His sense is that what happens in nature is that babies suckle on colostrum when they’re born. Colostrum is incredibly rich in Gc protein. In fact, the richest source of Gc protein in nature is in colostrum. So the baby suckles on colostrum, and it goes down into its GI tract, where the microorganisms called the microbiome. And those microorganisms can selectively deglycosolate the Gc protein. And the baby forms GcMAF in its little gut, and the GcMAF gains for it immunocompetence during its first days or weeks of life, preventing illness and sickness and death in infants from dysentery.



Screenshot-402.png


That’s how Dr. Ruggiero worked backwards. He said, “Nature has already designed this, so I’ll just redesign what nature has used to make GcMAF and I’ll give it to chronic fatigue syndrome patients.”

So basically over on the left side is the yogurt that we made from fresh milk. It contains a ferment capable of lopping off one sugar molecule from Gc protein.

And this is the kefir made with a different ferment capable of lopping off the second sugar. And the two combined wind up producing GcMAF in essentially a probiotic mixture of yogurt.

We pretty much set up the same experiment with this that we did with the chemical.

What we observed was that this study was much more potent and much more powerful in improving clinical status in our patients than the chemical GcMAF.

In some ways it’s more potent, and it’s also more natural.

The target turns out to be largely the cells in the gut that refer to the dendritic cells that have the infection with HERV’s. Maybe that’s why it works so well, because you put this right where the biggest problem is, in the gut.
 

Nemo

Member
Joined
Jul 8, 2019
Messages
2,163
Reminds me of this physician who was viciously attacked by the government and medical establishment in the 1970s for getting a great cure rate with cancer patients with laetrile and nutrition. He describes the treatment, his data, his mentors, and his attackers here: http://whale.to/m/binzel.html
 

Similar threads

Back
Top Bottom